Background: Firearm bone fractures are difficult to treat compared with general ones as both soft tissue and bone are injured more extensively and severely with contamination in the wound track. The bone morphogenetic protein (BMP) and transforming growth factor (TGF)-beta play an important role in bone fracture healing. Therefore, BMP-4 combined with TGF-beta1 was used to improve and accelerate the repair of rabbit femoral defect resulting from firearm.
Methods: Femoral defect was made with 0.375 g steel ball fired at 350 m/s. At 6 hours after wounding, the debridement and irrigation were performed, followed by trimming the ends of defected bone at day 7. Plasmid-encoded BMP-4 gene identified in vitro and TGF-beta1 were injected into the tissue of upper and lower parts and the epicenter of the defected area at 2 weeks after wounding, again TGF-beta1 was given at 5 weeks. At 3, 7, 11, and 15 weeks after wounding, the expression of mRNA and protein of BMP-4 were detected by reverse transcription-polymerase chain reaction and Western blot. The activity of alkaline phosphatase and calcium content were measured for describing osteogenetic ability. The course and quality of osteogenesis were determined quantitatively by pathohistological and X-ray examinations.
Results: In vivo BMP-4 mRNA and protein could be continually expressed for 8 weeks. The determination of alkaline phosphatase activity and calcium content showed osteogenetic ability was significantly enhanced by BMP-4 gene combined with TGF-beta1. The pathohistological and X-ray examinations revealed that osteogenetic speed was prominently accelerated, and the quality was improved after the treatment.
Conclusion: The repair of rabbit femoral defect resulting from firearm can be significantly improved and accelerated by BMP-4 gene combined with TGF-beta1.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/TA.0b013e3181848cd6 | DOI Listing |
Bioengineering (Basel)
January 2025
Department of Orthopaedic Surgery, Keck School of Medicine of the University of Southern California, Los Angeles, CA 90033, USA.
regional gene therapy is a promising tissue-engineering strategy for bone regeneration: osteogenic mesenchymal stem cells (MSCs) can be genetically modified to express an osteoinductive stimulus (e.g., bone morphogenetic protein-2), seeded onto an osteoconductive scaffold, and then implanted into a bone defect to exert a therapeutic effect.
View Article and Find Full Text PDFAnn Card Anaesth
January 2025
Department of Anaesthesia and Intensive Care, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Background: Congenital heart diseases (CHDs) are not rare and often require an intervention at some point of time. Pediatric cardiac catheterization, a minimally invasive procedure, is performed to diagnose and to correct many cardiac abnormalities. Deep sedation with spontaneously breathing patients is the preferred technique for pediatric catheterization in the pediatric population.
View Article and Find Full Text PDFStem Cell Res Ther
January 2025
Cellular Biopharma (Shanghai) Co., Ltd, Building 3, No.85, Faladi Road, Pudong New Area, Shanghai, 200233, China.
Background: Mesenchymal stem cells have great potential for repairing articular cartilage and treating knee osteoarthritis (KOA). Nonetheless, little is known about the efficacy of human adipose-derived mesenchymal stem cells (haMSCs) for KOA in large animal models.
Methods: This study evaluated the therapeutic efficacy of haMSCs in knee articular cartilage repair in a sheep model of KOA.
Bone Res
January 2025
Department of Endodontology, School of Dental Medicine, University of Connecticut Health, Farmington, CT, USA.
Craniometaphyseal dysplasia (CMD), a rare craniotubular disorder, occurs in an autosomal dominant (AD) or autosomal recessive (AR) form. CMD is characterized by hyperostosis of craniofacial bones and metaphyseal flaring of long bones. Many patients with CMD suffer from neurological symptoms.
View Article and Find Full Text PDFArthroscopy
February 2025
The Steadman Clinic, Vail, Colorado, U.S.A.; The Steadman Philippon Research Institute, Vail, Colorado, U.S.A.. Electronic address:
Revision hip arthroscopy is increasingly common and most often performed to treat residual femoroacetabular impingement caused by cam under-resection. Unfortunately, other pathologies encountered during revision hip arthroscopy are more difficult to treat, including capsular deficiency, labral deficiency, adhesion formation, and/or cam over-resection. When encountered, these various pathologies should be comprehensibly corrected with the goals of restoring anatomy, re-establishing the hip fluid seal, and ensuring impingement-free motion.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!